ATRT-17. TARGETING GLUTAMINE METABOLISM LOWERS METHYLATION POTENCIALS IN AT/RT AND SYNERGIZE WITH TAZEMETOSTAT
Satoshi Nakata(Johns Hopkins University), Jeffrey Rubens(Johns Hopkins University), Barbara S. Slusher(Johns Hopkins University), Eric H. Raabe(Johns Hopkins University), Jesse Alt(Johns Hopkins University), Sabrina Wang(Johns Hopkins Medicine), Charles G. Eberhart(The University of Texas MD Anderson Cancer Center)
Cited by 1
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711